Steroid withdrawal and reduction of cyclosporine A under mycophenolate mofetil after heart transplantation

International Immunopharmacology

Volumn 15, Issue 4, 2013, Pages 712-717

  Faulhaber, Marion ^a   Mäding, Ilona ^a   Malehsa, Doris ^a   Raggi, Matthias C ^b   Haverich, Axel ^a   Bara, Christoph L ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KLINIKUM STUTTGART   (Germany)

Author keywords

Heart transplantation; Immunosuppressive therapy; Low dose cyclosporine; Mycophenolate mofetil; Steroid withdrawal

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOSPORIN A; HEMOGLOBIN A1C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRIACYLGLYCEROL; UREA; URIC ACID;

ACUTE GRAFT REJECTION; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; HEALTH STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; MALE; NEOPLASM; OPPORTUNISTIC INFECTION; ORGAN DYSFUNCTION SCORE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK; RISK REDUCTION; SELF CONCEPT; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; WITHDRAWAL SYNDROME;

ADRENAL CORTEX HORMONES; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84875957894     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.02.012     Document Type: Article

References (57)

1. D.O. Taylor, J. Stehlik, L.B. Edwards, P. Aurora, J.D. Christie, and F. Dobbels Registry of the International Society for Heart and Lung Transplantation: twenty-sixth Official Adult Heart Transplant Report-2009 J Heart Lung Transplant 28 2009 1007 1022
2. R. John, H.A. Rajasinghe, J.M. Chen, A.D. Weinberg, P. Sinha, and D.M. Mancini Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy Ann Thorac Surg 72 2001 440 449 (Pubitemid 32727143)
3. T. van Gelder, A.H. Balk, R. Zietse, C. Hesse, B. Mochtar, and W. Weimar Renal insufficiency after heart transplantation: a case-control study Nephrol Dial Transplant 13 1998 2322 2326 (Pubitemid 28416560)
4. L. Frimat, J.P. Villemot, L. Cormier, T. Cao-Huu, E. Renoult, and D. Hestin Treatment of end-stage renal failure after heart transplantation Nephrol Dial Transplant 13 1998 2905 2908 (Pubitemid 28479543)
5. M. Grimm, M. Rinaldi, N.A. Yonan, G. Arpesella, J.M. Arizon Del Prado, and L.A. Pulpon Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients - a large European trial Am J Transplant 6 2006 1387 1397 (Pubitemid 44030321)
6. N. Romero-Rodriguez, E. Lage-Galle, A. Guisado-Rasco, J. Nevado-Portero, R.S. Rodriguez, and M.G. Machuca Survival after cardiac transplantation: influence of the previous cardiopathy in the recipient Transplant Proc 42 2010 3173 3174
7. M.I. Hertz, P. Aurora, J.D. Christie, F. Dobbels, L.B. Edwards, and R. Kirk Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation J Heart Lung Transplant 27 2008 937 942
8. A.O. Ojo, P.J. Held, F.K. Port, R.A. Wolfe, A.B. Leichtman, and E.W. Young Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931 940 (Pubitemid 37064766)
9. D.R. Davies, I. Bittmann, and J. Pardo Histopathology of calcineurin inhibitor-induced nephrotoxicity Transplantation 69 2000 SS11 SS13
10. I. Aleksic, M. Baryalei, T. Busch, B. Pieske, B. Schorn, and J. Strauch Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine Transplantation 69 2000 1586 1590
11. J. Lindenfeld, G.G. Miller, S.F. Shakar, R. Zolty, B.D. Lowes, and E.E. Wolfel Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs Circulation 110 2004 3858 3865 (Pubitemid 40023985)
12. J.A. Whitworth, P.M. Williamson, G. Mangos, and J.J. Kelly Cardiovascular consequences of cortisol excess Vasc Health Risk Manag 1 2005 291 299
13. C. Varas-Lorenzo, L.A. Rodriguez, A. Maguire, J. Castellsague, and S. Perez-Gutthann Use of oral corticosteroids and the risk of acute myocardial infarction Atherosclerosis 192 2007 376 383 (Pubitemid 46745271)
14. D.M. Becker, B. Chamberlain, R. Swank, M.G. Hegewald, R. Girardet, and K.L. Baughman Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients Am J Med 85 1988 632 638
15. J.P. Fryer, D.K. Granger, J.R. Leventhal, K. Gillingham, J.S. Najarian, and A.J. Matas Steroid-related complications in the cyclosporine era Clin Transplant 8 1994 224 229 (Pubitemid 24162292)
16. T.S. Mele, and P.F. Halloran The use of mycophenolate mofetil in transplant recipients Immunopharmacology 47 2000 215 245 (Pubitemid 30394540)
17. L.M. Birnbaum, M. Lipman, S. Paraskevas, P. Chaudhury, J. Tchervenkov, and D. Baran Management of chronic allograft nephropathy: a systematic review Clin J Am Soc Nephrol 4 2009 860 865
18. M.R. Weir, M.T. Ward, S.A. Blahut, D.K. Klassen, C.B. Cangro, and S.T. Bartlett Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy Kidney Int 59 2001 1567 1573 (Pubitemid 32281249)
19. H.J. Schlitt, A. Barkmann, K.H. Boker, H.H. Schmidt, N. Emmanouilidis, and J. Rosenau Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study Lancet 357 2001 587 591 (Pubitemid 32179611)
20. D.E. Hricik, and J.A. Schulak Metabolic effects of steroid withdrawal in adult renal transplant recipients Kidney Int Suppl 43 1993 S26 S29
21. D.E. Hricik, J. Lautman, M.R. Bartucci, E.J. Moir, J.T. Mayes, and J.A. Schulak Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients Transplantation 53 1992 1232 1235
22. Y. Vanrenterghem, Y. Lebranchu, R. Hene, F. Oppenheimer, and H. Ekberg Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection Transplantation 70 2000 1352 1359
23. J.M. Grinyo, S. Gil-Vernet, D. Seron, J.M. Cruzado, F. Moreso, and X. Fulladosa Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients Transplantation 63 1997 1688 1690 (Pubitemid 27265516)
24. N. Ahsan, D. Hricik, A. Matas, S. Rose, S. Tomlanovich, and A. Wilkinson Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Steroid Withdrawal Study Group Transplantation 68 1999 1865 1874 (Pubitemid 30027339)
25. J.P. Squifflet, Y. Vanrenterghem, J.P. van Hooff, K. Salmela, and P. Rigotti Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study Transplant Proc 34 2002 1584 1586
26. P.J. Smak Gregoor, R.G. de Sevaux, G. Ligtenberg, A.J. Hoitsma, R.J. Hene, and W. Weimar Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study J Am Soc Nephrol 13 2002 1365 1373 (Pubitemid 34441418)
27. S.A. Birkeland Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy Transplantation 66 1998 1207 1210 (Pubitemid 28530326)
28. C.A. McHorney, J.E. Ware Jr., and A.E. Raczek The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care 31 1993 247 263
29. T.R. Dawber, F.E. Moore, and G.V. Mann Coronary heart disease in the Framingham study Am J Public Health Nations Health 47 1957 4 24
30. B.D. Myers, and L. Newton Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury J Am Soc Nephrol 2 1991 S45 S52
31. D.E. Weiner, H. Tighiouart, M.G. Amin, P.C. Stark, B. MacLeod, and J.L. Griffith Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315 (Pubitemid 38526012)
32. J. Groetzner, I. Kaczmarek, J. Schirmer, P. Uberfuhr, H. Gulbins, and S. Daebritz Calcineurin inhibitor withdrawal and conversion to mycophenolate mofetil and steroids in cardiac transplant recipients with chronic renal failure: a word of caution Clin Transplant 22 2008 587 593
33. C.E. Angermann, S. Stork, A. Costard-Jackle, T.J. Dengler, U. Siebert, and G. Tenderich Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients - the IMPROVED multi-centre study Eur Heart J 25 2004 1626 1634 (Pubitemid 39209283)
34. N. Manito, G. Rabago, J. Palomo, J.M. Arizon, J. Delgado, and L. Almenar Improvement in chronic renal failure after mycophenolate mofetil introduction and cyclosporine dose reduction: four-year results from a cohort of heart transplant recipients Transplant Proc 43 2011 2699 2706
35. J. Moro, L. Almenar, L. Martinez-Dolz, J. Aguero, J. Rueda, and M.A. Arnau mTOR inhibitors: do they help preserve renal function? Transplant Proc 39 2007 2135 2137 (Pubitemid 47418173)
36. S.A. Schaffer, and H.J. Ross Everolimus: efficacy and safety in cardiac transplantation Expert Opin Drug Saf 9 2010 843 854
37. J.J. Teuteberg, M. Shullo, R. Zomak, D. McNamara, K. McCurry, and R.L. Kormos Aggressive steroid weaning after cardiac transplantation is possible without the additional risk of significant rejection Clin Transplant 22 2008 730 737
38. M.A. Castel, I. Vallejos, P. Ramos, A. Arias, C. Bravo, and M. Ferrero Outcome after steroid withdrawal in heart transplantation Transplant Proc 41 2009 2253 2255
39. F.C. Mazali, and M. Mazzali Uric Acid and transplantation Semin Nephrol 31 2011 466 471
40. M. Kanbay, B. Afsar, and A. Covic Uric acid as a cardiometabolic risk factor: to be or not to be Contrib Nephrol 171 2011 62 67
41. D.I. Feig, D.H. Kang, and R.J. Johnson Uric acid and cardiovascular risk N Engl J Med 359 2008 1811 1821
42. N. Antonio, D. Prieto, and M.J. Antunes Uric acid: a prognostic marker not only before but also after heart transplantation Eur J Cardiothorac Surg 38 2010 187 191
43. N. Robert, G.W. Wong, and J.M. Wright Effect of cyclosporine on blood pressure Cochrane Database Syst Rev 2010 CD007893
44. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
45. S.R. Maxwell, R.J. Moots, and M.J. Kendall Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 70 1994 863 870
46. R.N. Clayton, D. Raskauskiene, R.C. Reulen, and P.W. Jones Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature J Clin Endocrinol Metab 96 2011 632 642
47. C.D. Robinette, and J.F. Fraumeni Jr. Asthma and subsequent mortality in World War II veterans J Chronic Dis 31 1978 619 624 (Pubitemid 9086219)
48. T.M. Sartori, P.G. Maurizio, P. Sara, L. Ugolino, A. Annalisa, and T. Panagiotis Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation J Heart Lung Transplant 18 1999 693 700 (Pubitemid 29362005)
49. S.A. Lubitz, D.A. Baran, M.M. Alwarshetty, M.J. Zucker, L.H. Arroyo, and M. Chan Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation Transplant Proc 38 2006 1501 1506
50. M. Arnol, A.M. de Mattos, J.S. Chung, J.C. Prather, A. Mittalhenkle, and D.J. Norman Late steroid withdrawal and cardiovascular events in kidney transplant recipients Transplantation 86 2008 1844 1848
51. S.R. Knight, and P.J. Morris Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk A meta-analysis. Transplantation 89 2010 1 14
52. D.H. Rosenbaum, B.C. Adams, J.D. Mitchell, M.E. Jessen, M.C. Paul, and P.A. Kaiser Effects of early steroid withdrawal after heart transplantation Ann Thorac Surg 82 2006 637 644 [discussion 44] (Pubitemid 44088648)
53. S.R. Knight, and P.J. Morris Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis Transpl Int Dec 24 12 2011 1198 1207 10.1111/j.1432-2277.2011.01335.x
54. Z. Hochberg, K. Pacak, and G.P. Chrousos Endocrine withdrawal syndromes Endocr Rev 24 2003 523 538 (Pubitemid 37056242)
55. L. Margolin, D.K. Cope, R. Bakst-Sisser, and J. Greenspan The steroid withdrawal syndrome: a review of the implications, etiology, and treatments J Pain Symptom Manage 33 2007 224 228 (Pubitemid 46186869)
56. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 63 (Pubitemid 27446271)
57. C. Alves, T.C. Robazzi, and M. Mendonca Withdrawal from glucocorticosteroid therapy: clinical practice recommendations J Pediatr (Rio J) 84 2008 192 202 (Pubitemid 351840284)